Full-Time
Confirmed live in the last 24 hours
Develops precision oncology treatments for cancer
Senior, Expert
Boston, MA, USA
Scorpion Therapeutics develops precision oncology treatments aimed at targeting specific cancer drivers. Their approach involves creating drugs that interact with validated cancer targets, enhancing their selectivity and safety to improve treatment outcomes. Unlike many competitors, Scorpion Therapeutics focuses on forming partnerships with larger pharmaceutical companies for the distribution of their drugs, allowing them to concentrate on research and development. Their goal is to provide effective cancer therapies that can be rapidly deployed to healthcare providers and patients worldwide.
Company Stage
Series A
Total Funding
$132.7M
Headquarters
Boston, Massachusetts
Founded
2020